Mapping the role of NAD metabolism in prevention and treatment of carcinogenesis

  • Elaine L. Jacobson
  • W. Melissa Shieh
  • Arnold C. Huang
Part of the Molecular and Cellular Biochemistry: An International Journal for Chemical Biology in Health and Disease book series (DMCB, volume 30)


Studies presented here show that cellular NAD, which we hypothesize to be the relevant biomarker of niacin status, is significantly lower in humans than in the commonly studied animal models of carcinogenesis. We show that nicotinamide and the resulting cellular NAD concentration modulate expression of the tumor suppressor protein, p53, in human breast, skin, and lung cells. Studies to determine the optimal NAD concentrations for responding to DNA damage in breast epithelial cells reveal that DNA damage appears to stimulate NAD biosynthesis and that recovery from DNA damage occurs several hours earlier in the presence of higher NAD or in cells undergoing active NAD biosynthesis. Finally, analyses of normal human skin tissue from individuals diagnosed with actinic kératoses or squamous cell carcinomas show that NAD content of the skin is inversely correlated with the malignant phenotype. Since NAD is important in modulating ADP-ribose polymer metabolism, cyclic ADP-ribose synthesis, and stress response proteins, such as p53, following DNA damage, understanding how NAD metabolism is regulated in the human has important implications in developing both prevention and treatment strategies in carcinogenesis.

Key words

skin lung and breast cancer p53 expression cyclic ADP-ribose poly(ADP-ribose) metabolism niacin status 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jacobson EL, Smith JY, Wielckens K, Hilz H, Jacobson MK: Cellular recovery of dividing and confluent C3H10T1/2 cells from N-methyl-N-nitro-N-nitrosoguanidine in the presence of ADP-ribosylation inhibitors. Carcinogenesis 6: 715–718, 1985PubMedCrossRefGoogle Scholar
  2. 2.
    Shah GM, Shah RG, Poirier GG: Different cleavage pattern for poly(ADP-ribose) polymerase during necrosis and apoptosis in HL-60 cells. Biochem Biophys Res Commun 229: 838–844, 1996PubMedCrossRefGoogle Scholar
  3. 3.
    Vu CQ, Coyle DL, Tai H-H, Jacobson EL, Jacobson MK: Intramolecular ADP-ribose transfer reactions and calcium signalling. In: F. Haag, F. Koch-Nolte (eds). ADP-Ribosylation in Animal Tissues: Structure, Function, and Biology of Mono-ADP-Ribosyltransferases and Related Enzymes. Plenum Press, New York, 1997, pp 381–388Google Scholar
  4. 4.
    Vu CQ, Coyle DL, Jacobson EL, Jacobson MK: Intracellular signaling by cyclic ADP-ribose in oxidative cell death. FASEB J 11:Al 116, 1997Google Scholar
  5. 5.
    Wright SC, Wei QS, Kinder DH, Larrick JW: Biochemical pathways of apoptosis: nicotinamide adenine dinucleotide-deficient cells are resistant to tumor necrosis factor or ultraviolet light activation of the 24-kD apoptotic protease and DNA fragmentation. J Exp Med 183: 463–471, 1996PubMedCrossRefGoogle Scholar
  6. 6.
    Whitacre CM, Hashimoto H, Hashimoto S, Tsai M-L, Chatterjee S, Berger SJ, Berger NA: Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences. Cancer Res 55: 3697–3701, 1995PubMedGoogle Scholar
  7. 7.
    Nutrition monitoring in the United States: A progress report from the joint nutrition monitoring evaluation committee. Vol DHHS Publication No.(PHS)86-1255, 1986Google Scholar
  8. 8.
    Fu CS, Swendseid ME, Jacob RA, McKee RW: Biochemical markers for assessment of niacin status in young men: Levels of erythrocyte niacin coenzymes and plasma tryptophan. J Nutr 119: 1949–1955, 1989PubMedGoogle Scholar
  9. 9.
    Jacobson EL, Dame A, Pyrek JS, Jacobson MK: Evaluating the role of niacin in human carcinogenesis. Biochimie 77: 394–398, 1995PubMedCrossRefGoogle Scholar
  10. 10.
    Jacobson EL, Huang AC, Williams T, Gensler HL: Chemoprevention by niacin in a mouse model of UV-induced skin carcinogenesis. Proc Am Assoc Cancer Res 37: A279, 1996Google Scholar
  11. 11.
    Zhang JZ, Henning SM, Swendseid ME: Poly (ADP-ribose) polymerase activity and DNA strand breaks are affected in tissues of niacin deficient rats. J Nutr 123: 1349–1355, 1993PubMedGoogle Scholar
  12. 12.
    Rawling JM, Jackson TM, Driscoll E, Kirkland JB: Dietary niacin deficiency lowers tissue poly(ADP-ribose) and NAD+ concentrations in Fischer-344 rats. J Nutr 124: 1597–1603, 1994PubMedGoogle Scholar
  13. 13.
    Shibata K, Murata K: Blood NAD as an index of niacin nutrition. Nutr Inter 2: 177–181, 1986Google Scholar
  14. 14.
    Jacobson EL, Jacobson MK: Tissue NAD as a biochemical measure of niacin status in humans. Meth Enzymol 280: 221–230, 1997PubMedCrossRefGoogle Scholar
  15. 15.
    Jacobson EL, Jacobson MK: A biomarker for the assessment of niacin nutriture as a potential preventive factor in carcinogenesis. J Int Med 233: 59–62, 1993CrossRefGoogle Scholar
  16. 16.
    Jacobson EL: Niacin deficiency and cancer in women. J Am Coll Nutr 12: 412–416, 1993PubMedGoogle Scholar
  17. 17.
    Kirkland JB, Rawling JM: Niacin. In: R. Rucker, J. Suttie, D. McCormick, L. Machlin (eds). Handbook of Vitamins, 3rd ed. Marcel Dekker, New York, 1998 (in press)Google Scholar
  18. 18.
    Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356: 215–221, 1992PubMedCrossRefGoogle Scholar
  19. 19.
    Bradford MM: A rapid and sensitive method for the quantitation of microgram, quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254, 1976PubMedCrossRefGoogle Scholar
  20. 20.
    Hammond SL, Ham RG, Stampfer MR: Serum-free growth of human mammary epithelial cells: Rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc Nati Acad Sci 81: 5435–5439, 1984CrossRefGoogle Scholar
  21. 21.
    McKeehan WL, McKeehan KA, Hammond SL, Ham RG: Improved medium for clonal growth of human diploid fibroblasts at low concentrations of serum protein. In Vitro 13: 399–416, 1977PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Elaine L. Jacobson
    • 1
    • 2
    • 3
    • 4
    • 5
  • W. Melissa Shieh
    • 1
  • Arnold C. Huang
    • 2
  1. 1.Department of Clinical SciencesLexingtonUSA
  2. 2.Multidisciplinary Program in Nutritional SciencesLexingtonUSA
  3. 3.Advanced Science and Technology Commercialization CenterLexingtonUSA
  4. 4.Lucille P. Markey Cancer CenterUniversity of KentuckyLexingtonUSA
  5. 5.University of KentuckyLexingtonUSA

Personalised recommendations